Advanced Search
Contact | Corporate | Help

Daily news email for February 03, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
IDEA Bio-Medical Sells HTS/HCS Cell Imaging System to The Medical University of South Carolina

Biotage Introduces Biotage® SNAP Ultra High Performance Flash Chromatography Cartridges

Definiens Strengthens Leadership with Key Appointment

Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science

Rentschler Announces 2. Laupheimer Zelltage on Industrial Cell Culture Technology

 BioSpace
Erratic Heart Rhythm May Account for Some Unexplained Strokes, Henry Ford Hospital Study

Merck & Co., Inc. Swings to Profit on Fewer Charges, Sales Growth

Identical Twins Reveal Mechanisms Behind Aging, Uppsala Universitet Study

Sleep Apnea Ups Risk of Silent Strokes, Study

Rapid Nerve Repair Helps Lame Rats Walk Within Days, University of Texas Study

BioSpace - Breaking News
MannKind Corporation Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock

CORRECTING and REPLACING Cook Medical Launches Zenith Low Profile Endovascular Graft in Canada

Bristol-Myers Squibb Company Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibetex Therapeutics Inc.

MannKind Corporation Receives Commitment from the Mann Group to Acquire 31,250,000 Shares of Common Stock

Synthetic Genetics and Integrated DNA Technologies Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology

Biotech News - Business Wire
Research and Markets: International Directory of Biotechnology Companies 2012: a must-have for anyone who needs to find contacts in the biotechnology sector worldwide

Arcadia450

Natera's Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalities in the First Trimester of Pregnancy

Sirona Reports Fiscal 2012 First Quarter Results

RBCC: Biotech Industry on Major Upswing in 2012

 Biotech News - PR Newswire
Cempra, Inc. Announces Pricing of Its Initial Public Offering of Common Stock

3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results

Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting

Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184

Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Big Biotech Fuels M&A Activity

Hitting the Target

Infinity Pharmaceuticals Tanks on Failed Cancer Drug Trial

Gates Gives Global Fund $750 Million Boost

Novo to Launch Type 1 Diabetes R&D Center

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Cancer Research Organization Broadcasts Healthy Eating Tips with Top Chefs around the Country

ISCTM Pushes for Innovation in the Development of Novel Therapies for CNS Disorders

Se anunciarán los resultados del estudio «Solitaire with the Intention for Thrombectomy (SWIFT)» en el Congreso Internacional de ACV el 3 de febrero

Les résultats de l'étude SWIFT (Solitaire with the Intention for Thrombectomy) seront annoncés le 3 février lors de la conférence internationale sur les AVC

Celebrating 50 Years of Breakthroughs: Bascom Palmer Eye Institute Hosts Global Scientific Meeting, Announces Plans to Expand Clinical Trial Access and Collaborative Research

 Clinical Trials - PR Newswire
Stryker présente les résultats de l'étude clinique prospective TREVO à l'International Stroke Conference

Stryker presenta los resultados del estudio clínico prospectivo TREVO

Genomic Health Presents Results Furthering Understanding of Biology of Prostate Cancer at the 2012 Genitourinary Cancers Symposium

High Triglyceride Levels Found to Predict Stroke in Older Women

Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference

 CNN Top Stories
Military to get secure Android phones

Protests in Egypt escalate

Group: Syrian forces torture children

Dermatologists get cheating warning

2 Americans kidnapped in Egypt
Contract Pharma
Syntagon Adds Quality Assurance Expert

SCM Pharma to Provide Product for BrePco BioPharma Trials

Melbourn Scientific Names Operations Director

Financial Report: Gilead Sciences

Excella Plant Gains SafeBridge Certification

 FDA Drugs- What's New
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)

Medication Guides

FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)

FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82

FDA Statement on recently terminated clinical trial with Doribax (doripenem)

 FDA News - Business Wire
FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience

OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology

Regulatory Harmonization Institute and Korea Health Industry Development Institute Partner to Launch 2012 Columbus Project

La FDA acelera la evaluación de un nuevo medicamento para el cáncer de piel, mientras que Cannabis Science ofrece un tratamiento tópico para el carcinoma basocelular sin efectos secundarios aparentes

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
FDA Press Releases
FDA and industry reach agreement in principle on medical device user fees

FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer

FDA takes action against New York cheese manufacturer

FDA approves Kalydeco to treat rare form of cystic fibrosis

FDA approves new treatment for most common type of skin cancer

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

 FierceBiotech
Idenix gets good news on hep C trial, but can't compete with Gilead

Scoring winners and losers in Japan pharma M&A bout

AstraZeneca's R&D chief in China lays out $100M strategy

AstraZeneca's R&D chief in China lays out its $100M strategy

Gilead shares surge as hep C drug scores a cure for big patient population
FierceBiotech IT
Startups ease access to online data on medical product side effects

Google Ventures, VCs backing tech focused on genomics

Clinical IT outfit upsizes as Big Pharma customers downsize

U.K. genomics database plan faces hurdles

Covance's big IT budget gets thumbs down from analysts

FierceBiotech Research
Stem cells solve hepatitis C research dilemma

Mutated melanoma receptor heightens diabetes risk

Team finds 2 mutations that cause pediatric brain cancer

Meet cancer's latest enemy: grape seed extract

Nearly $11M to fund new Joslin Diabetes Center research facility

FiercePharma
Botox delivers for Allergan, Dr. Reddy's sees big profit increase during quarter

Astellas scores highest in Japanese M&A bout

FDA talks, but doctors don't necessarily listen

Gloom for the pharma industry, yes. Doom No

Mediator probe rolls on with searches at Afssaps, executives' homes
FiercePharma Manufacturing
Executive suite not spared in J&J reorg tied to quality concerns

Medical devicemakers double down on FDA

Pfizer suspects 30 packs of contraceptives mispackaged; pulls 1 million just in case

Roche plant spared from sale runs into GMP issues

Amylin's OH plant prepped for Bydureon's U.S. debut

 FierceVaccines
Women's own cells could blast breast cancer

Universal flu vaccine might be a step closer

First hookworm vaccine enters clinical trials

Ovarian cancer vaccine clinical trial begins enrollment

Study: Gardasil does not cause autoimmune disease

 Health News - BizJournals.com
JRMC expands services for women

Vertex roiled by fickle market

College-loan program incentivizes dentists who work in rural areas

Questions raised as Blue Cross opts out of Kansas Medicaid reform

North Carolina's $2.6B health plan with Blue Cross up for bid
Health News - CNBC
Allergan to rely less on U.S. for sales, Asia key

Turnaround for Japan Market in Q2

Komen struggles to defuse Planned Parenthood crisis

Bossy mom at snack time tied to kid's weight: study

Vertex posts 4Q profit on growing Incivek sales

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Agennix Stops Phase II/III Talactoferrin Study in Sepsis Due to Higher Death Rates

PDUFA V Supporters Try to Sell Congress on Job, Innovation Potential

Athersys MultiStem Program Gets $3.6M Boost

Shire, Sangamo Ink $13M Up-Front Deal for ZFPs against Hemophilia and Monogenic Disorders

Roche's Cobas Test for Chlamydia and Gonorrhea Granted 510(k) Clearance in U.S.
Marketwire - Pharma and Biotech
Corporate Profile's CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on Medgenics

Cerecor Announces Scientific Advisory Board

BC Bioenergy Network Invests $1.5 M in Fraser Richmond Soil and Fibre "Energy Garden"-an Innovative Organic Waste to Energy Demonstration

Methodist Orthopedics and Sports Medicine Specialists Named Among 2011-2012 Texas Super Doctors -- Featured in Texas Monthly as Best in Texas Healthcare

Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 2 February 2012

 MassBio News
NUCLEA BIOTECHNOLOGIES ANNOUNCES $3.4 MILLION IN CAPITAL COMMITMENTS

Annual Policy Breakfast Makes Headlines on Healthcare Reform

MassBio Introduces the Leading Edge Award

MassBio Policy Update - SBIR Reauthorization

451 Marketing & Freeman to Create Massachusetts Pavilion at 2012 BIO International Convention

 Medical Pharma - PR Newswire
meridianMobile for iPhone

Diagnostic Imaging Northwest Announces the First Extremity MRI Scanner in Northwest

Questcor Announces Preliminary Fourth Quarter and Full Year 2011 Net Sales and Operating Income

Prometheus Announces New Chief Commercial Officer

Federal Court Dismisses Whistleblower Lawsuit Against Millennium Laboratories
National Center for Biotechnology Information
GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

SRA News

 Nature Biotechnology
Approval on a knife edge

Bringing business risk into sharp focus

The NIH's role in accelerating translational sciences

Building stem-cell genomics in California and beyond

Foundation Medicine

 New York Times- Biotechnology
Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

DNA Sequencing Caught in Deluge of Data
New York Times- Pharmaceuticals
Children’s A.D.D. Drugs Don’t Work Long-Term

Army Studies Workout Supplements After 2 Deaths

Pfizer and Eli Lilly, Squeezed by Generics, Top Forecasts

F.D.A. Approves Cystic Fibrosis Drug

F.D.A. Approves Drug for an Advanced Skin Cancer

 OnBioVC
CeNeRx BioPharma, Inc.: Series D $4.6M

MedLumics: Series A $4.7M

CircuLite, Inc.: Series D $30M

TopiVert, Ltd.: Series A $12.5M

HealthTap, Inc.: Series A $11.5M

 Outsourcing-Pharma
An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Recipharm CEO talks CMO sector recovery and Asian plans

Covance adding mass spec for biosimilars
Pharma News - Business Wire
Research and Markets: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)

DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs

Russell Reynolds Associates Interviews AstraZeneca CEO David Brennan

Incyte to Present at the Leerink Swann 2012 Global Healthcare Conference

Walgreens January Sales Decrease 2.3 Percent

 Pharma News - PharmiWeb
Molecular Profiles Invests £9 million in New Facility To Increase Manufacturing Capabilities for Phase I and II Clinical Trials

Michael Kaufmann of Cardinal Health Named as the Healthcare Businesswomen's Association's 2012 Honorable Mentor

Evergreen Awarded Distinguished Hospital for Clinical Excellence for the Fourth Consecutive Year

New data published in New England Journal of Medicine confirm the efficacy of Esmya® (ulipristal acetate) for the pre-operative treatment of uterine fibroids

Partner With Your Pharmacist to Monitor Heart Health

 Pharma News - PR Newswire
Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI

Cardinal Health Inc. Seeks Restraining Order to Avoid Disruption in Controlled Medicine Shipments from Florida

Mission Pharmacal Acquires Eletone Cream from Ferndale Healthcare, Inc.

En honor al Mes del Corazón en los Estados Unidos Joy Behar y su hija Eve acuden a las mujeres para que asuman el compromiso ProHeart (a Favor del Corazón) en Facebook

Watson Provides Update on Generic Lidoderm® Application
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

 PRWeb - Biotechnology
invivodata Co-Founder Dr. Saul Shiffman Recognized by Carnegie Science...

National Professional Science Master's Association Presents...

Diagnostic Device Becomes Mobile - The Handheld Flow Cytometer...

J.G. Finneran Introduces the 300µL Interlocked R.A.M. Vial

Thermo Fisher Scientific Awarded Patent for Cell Factory System
PRWeb - Pharmaceuticals
Patient Conversation Media, Inc. Network Reaches 10 Million Unique...

Kelo-cote The Leader In Scar Treatments Selects Vayu Media For...

Meridia Audience Response Helps Clients on Both Sides of the Atlantic

The US Drug Watchdog Expands Its Vital Yaz Yasmin Birth Control Pill...

Heartburn drugs increase the risk of hip fracture: AttorneyOne.com...

 Scientific American
Virtual Reality Contact Lenses Could Be Available by 2014

Temperatures--Not Acid--Could Cook Coral to Death

Newfound Alien Planet is Best Candidate Yet to Support Life, Scientists Say

Thanks to Plants, We Will Never Find A Planet Like Earth

Did Leonardo da Vinci Copy His Famous "Vitruvian Man"

 Sports - ESPN Basketball
Stout defense helps BYU pull away from Zags

BYU jumps to big lead, holds on to beat Zags

St. Mary's survives scare for 12th straight win

Beal's double-double lifts Florida by S. Carolina

Canaan's 32 helps Murray St. stay unbeaten
Sports News - ESPN
Schlabach: Colleges line up for 2013's top prospect

Houston students vote in favor of stadium fee

Former Illinois coach Tepper is new Buffalo DC

LSU's Miles questions Kiel's leadership ability

Alabama, artist in court over football paintings

 Xconomy Life Sciences
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy

FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News

Wayne State Hires Former Pharma Exec to Lead Tech Commercialization Efforts

San Diego Life Sciences Strengthened in Recession, Outpacing Nation

Flagship Ventures Plans to Open Michigan Office

 Yahoo Biotech News
Sex & Parenting Genes Discovered in Mice (LiveScience.com)

Same Genes Key to Early & Late-Onset Alzheimer's: Study (HealthDay)

Romney stock trades clash with divestment pledge (AP)

Stem Cell Therapy Shows Promise for Stroke, Studies Say (HealthDay)

Gene Study Sheds Light on Body Clock's Link to Diabetes (HealthDay)


SourceSolution © 2008-2012